Propylthiouracil (PTU) is an antithyroid medication used primarily to manage hyperthyroidism. It works by inhibiting the production of thyroid hormones in the thyroid gland, thereby reducing symptoms associated with hyperthyroidism.
Propylthiouracil is used for:
| Brand Name | Propylthiouracil |
|---|---|
| Type | |
| Weight | |
| Generic | Propylthiouracil |
| Manufacturer | |
| Available in | English বাংলা |
Propylthiouracil works by inhibiting thyroid peroxidase, an enzyme crucial for the synthesis of thyroid hormones. By blocking this enzyme, PTU prevents the iodination of tyrosine residues in the thyroid gland, which is essential for the formation of thyroxine (T4) and triiodothyronine (T3). Additionally, PTU reduces the conversion of T4 to the more active T3 in peripheral tissues.
The onset of action of Propylthiouracil can vary but typically begins within 1-2 weeks of starting treatment. Full therapeutic effects may take several weeks to months as the body's existing thyroid hormone stores are gradually depleted.
Propylthiouracil is well absorbed from the gastrointestinal tract following oral administration. Peak plasma concentrations are typically reached within 1-2 hours after ingestion.
Propylthiouracil is primarily metabolized in the liver. It is excreted mainly through the urine, with a smaller fraction being excreted in the bile.
The dosage of Propylthiouracil is individualized based on the patient's thyroid function tests and clinical response:
Propylthiouracil should be administered orally, with or without food. It is important to follow the prescribed dosage and schedule to effectively manage hyperthyroidism and minimize side effects.
Common side effects of Propylthiouracil include:
Propylthiouracil toxicity can manifest as severe hepatotoxicity or agranulocytosis. Regular monitoring of liver function and blood cell counts is necessary to detect and manage these adverse effects promptly.
Precautions include:
Propylthiouracil may interact with other medications, including:
Propylthiouracil should be used with caution in patients with liver disease, blood disorders, or a history of hypersensitivity to the drug.
Potential drug interactions include:
There are no significant food interactions with Propylthiouracil . However, it is advisable to maintain a consistent diet and take the medication as directed to ensure optimal absorption and effectiveness.
Propylthiouracil is considered a Category D medication during pregnancy, meaning it may pose risks to the fetus. It is generally used when the benefits outweigh the risks, and the dosage should be carefully monitored by a healthcare provider.
Propylthiouracil is excreted in breast milk, but it is generally considered acceptable for use during lactation if the benefits outweigh the risks. Monitor the infant for potential adverse effects.
Acute overdose of Propylthiouracil may lead to severe side effects, including hepatotoxicity or agranulocytosis. Immediate medical attention is required if overdose is suspected, and symptomatic treatment should be initiated.
Contraindications include:
Administer Propylthiouracil orally as directed by a healthcare provider. Adhere to the prescribed dosage and schedule, and attend regular follow-up appointments for monitoring and dose adjustments.
Store Propylthiouracil at room temperature, away from moisture and heat. Keep it in a tightly closed container out of reach of children.
The volume of distribution for Propylthiouracil is not well-defined but is generally low due to its protein binding characteristics and tissue distribution.
The half-life of Propylthiouracil is approximately 1-2 hours, though its clinical effects last longer due to its impact on thyroid hormone synthesis and metabolism.
Propylthiouracil is primarily cleared by the liver, with renal excretion playing a minor role. The rate of clearance can vary based on liver function and other factors.
See in details version Propylthiouracil also Propylthiouracil in bangla